Name Funds holding
in top 10
Growth Growth % Return since
30 Jun ‘16
126
7 +2 +40% 1.9%
127
7 +2 +40% 150%
128
7 +2 +40% 310%
BMY icon
129
Bristol-Myers Squibb
BMY
$112B
110 +31 +39% 24.9%
130
18 +5 +38% 107%
131
11 +3 +38% 340%
132
11 +3 +38% 164%
133
11 +3 +38% 359%
134
11 +3 +38% 398%
135
11 +3 +38% 859%
NTES icon
136
NetEase
NTES
$87.4B
30 +8 +36% 257%
137
15 +4 +36% 102%
138
15 +4 +36% 64.5%
139
19 +5 +36% 395%
140
43 +11 +34% 32%
141
47 +12 +34% 157%
142
71 +18 +34% 61.6%
143
64 +16 +33% 135%
144
20 +5 +33% 142%
145
16 +4 +33% 64.3%
146
12 +3 +33% 199%
147
8 +2 +33% 1,375%
148
8 +2 +33% 56.3%
149
8 +2 +33% 3.34%
150
4 +1 +33% 170%